Summit buys microkeratome from EyeTech Vision
This article was originally published in Clinica
Executive Summary
Ophthalmic laser company Summit Technology has bought the Krumeich-Barraquer microkeratome from EyeTech Vision, which is based in Liechtenstein and the US, for an undisclosed sum. Summit will begin selling the high precision, corneal surgical device to international customers immediately. The Waltham, Massachusetts-based company will commence sales in the US upon receipt of FDA 510(k) clearance.